These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12096151)

  • 1. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003336. PubMed ID: 11687190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; KozieĊ‚ M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC; Dwivedi G
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
    Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S
    J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Massel DR; Little SH
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003464. PubMed ID: 23839768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
    Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D
    PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Little SH; Massel DR
    Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Vemmos K; Lip GY
    Int J Stroke; 2019 Dec; 14(9):856-861. PubMed ID: 31526132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
    Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials.
    Liew AY; Eikelboom JW; Connolly SJ; O' Donnell M; Hart RG
    Int J Stroke; 2014 Feb; 9(2):199-206. PubMed ID: 23506160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.